- Report
- April 2025
- 200 Pages
Global
From €4020EUR$4,490USD£3,499GBP
- Report
- May 2025
- 184 Pages
Global
From €3174EUR$3,545USD£2,763GBP
€3527EUR$3,939USD£3,070GBP
- Report
- May 2025
- 180 Pages
Global
From €3174EUR$3,545USD£2,763GBP
€3527EUR$3,939USD£3,070GBP
- Report
- May 2025
- 190 Pages
Global
From €3174EUR$3,545USD£2,763GBP
€3527EUR$3,939USD£3,070GBP
- Report
- May 2025
- 193 Pages
Global
From €3174EUR$3,545USD£2,763GBP
€3527EUR$3,939USD£3,070GBP
- Report
- May 2025
- 188 Pages
Global
From €3174EUR$3,545USD£2,763GBP
€3527EUR$3,939USD£3,070GBP
- Report
- May 2025
- 182 Pages
Global
From €3174EUR$3,545USD£2,763GBP
€3527EUR$3,939USD£3,070GBP
- Report
- May 2025
- 199 Pages
Global
From €3174EUR$3,545USD£2,763GBP
€3527EUR$3,939USD£3,070GBP
- Report
- March 2025
- 200 Pages
Global
From €2230EUR$2,490USD£1,941GBP
- Report
- March 2025
- 200 Pages
Global
From €4020EUR$4,490USD£3,499GBP
- Report
- March 2025
- 175 Pages
Global
From €4020EUR$4,490USD£3,499GBP
- Report
- February 2025
- 200 Pages
Global
From €4020EUR$4,490USD£3,499GBP
- Report
- February 2025
- 200 Pages
Global
From €4020EUR$4,490USD£3,499GBP
- Report
- February 2025
- 200 Pages
Global
From €4020EUR$4,490USD£3,499GBP
- Report
- January 2025
- 175 Pages
Global
From €4020EUR$4,490USD£3,499GBP
- Report
- January 2025
- 175 Pages
Global
From €4020EUR$4,490USD£3,499GBP
- Report
- June 2025
- 299 Pages
Global
From €5238EUR$5,850USD£4,559GBP
- Report
- April 2025
- 150 Pages
Global
From €3447EUR$3,850USD£3,000GBP
€4343EUR$4,850USD£3,780GBP
- Report
- July 2025
- 175 Pages
Global
From €4020EUR$4,490USD£3,499GBP
- Report
- May 2025
- 175 Pages
Global
From €4020EUR$4,490USD£3,499GBP

The Vasodilator market is a segment of the Medical Devices industry that focuses on the development and sale of products used to widen blood vessels. These products are used to treat a variety of conditions, including hypertension, coronary artery disease, and peripheral vascular disease. Vasodilators are typically administered through injection, infusion, or inhalation, and can be used to reduce blood pressure, improve blood flow, and reduce the risk of stroke and heart attack.
The Vasodilator market is highly competitive, with a number of large and small companies offering a variety of products. Major players in the market include Pfizer, Merck, Novartis, and Sanofi, while smaller companies such as Bausch Health, Mylan, and Teva Pharmaceuticals also offer products. Additionally, many generic drug manufacturers produce generic versions of popular vasodilators. Show Less Read more